Related Experiment Videos
"...those left behind." Biology and oncology of invasive glioma cells
1Neuro-Oncology Laboratory, Barrow Neurological Institute, Saint Joseph's Hospital and Medical Center, Phoenix, AZ 85013-4496, USA. mberens@chw.edu
Abstract:
Although significant technical advances in surgical and radiation treatment for brain tumors have emerged in recent years, their impact on clinical outcome for patients has been disappointing. A fundamental source of the management challenge presented by glioma patients is the insidious propensity of the malignant cells to invade into adjacent normal brain. Invasive tumor cells escape surgical removal and geographically dodge lethal radiation exposure. Recent improved understanding of the biochemistry and molecular determinants of glioma cell invasion provide valuable insight to the underlying biological features of the disease, as well as illuminating possible new therapeutic targets. Heightened commitment to migrate and invade is accompanied by a glioma cell's reduced proliferative activity. The microenvironmental manipulations coincident to invasion and migration may also impact the glioma cell's response to cytotoxic treatments. These collateral aspects of the glioma cell invasive phenotype should be further explored and exploited as novel antiglioma therapies.
Insights
Glioma cell invasion into the brain hinders effective treatment. Understanding the molecular drivers of this invasion may reveal new therapeutic targets for brain tumors.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Molecular Medicine
Background:
- Despite advances in surgery and radiation, patient outcomes for brain tumors, particularly gliomas, remain poor.
- A primary challenge in glioma management is the invasive nature of malignant cells, allowing them to infiltrate surrounding brain tissue.
- This invasion enables tumor cells to evade surgical resection and radiation therapy, contributing to treatment failure.
Purpose of the Study:
- To explore the biological features and molecular determinants of glioma cell invasion.
- To identify potential new therapeutic targets based on the understanding of invasion mechanisms.
- To investigate how the invasive phenotype influences glioma cell response to cytotoxic treatments.
Main Methods:
- Review of recent technical advances in brain tumor treatment.
- Analysis of the biochemical and molecular mechanisms underlying glioma cell invasion.
- Exploration of the relationship between glioma cell migration, invasion, and proliferation.
- Investigation of microenvironmental factors affecting glioma cell invasiveness and treatment response.
Main Results:
- Glioma cell invasion is a key factor limiting the efficacy of current brain tumor treatments.
- Understanding the molecular basis of invasion offers insights into the disease's biology.
- A heightened propensity for migration and invasion correlates with reduced glioma cell proliferation.
- The tumor microenvironment associated with invasion may modulate glioma cell sensitivity to therapy.
Conclusions:
- New therapeutic strategies targeting glioma cell invasion are needed.
- Exploiting the collateral aspects of the invasive phenotype could lead to novel anti-glioma therapies.
- Further research into the interplay between invasion, proliferation, and the microenvironment is crucial for developing effective treatments.